Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Maziarz · SciRah

Researcher profile · Semantic Scholar

R. Maziarz

Share profile

R. Maziarz — researcher profile on SciRah

h-index: 88
Works: 662
Citations: 31K

Most-cited papers

Anakinra for refractory CRS or ICANS after CAR T-cell therapy
Nicolas Gazeau, Emily C. Liang, Q. Wu, J. Voutsinas +20 more
2023Transplantation and Cellular Therapy128 citations Open access
Semantic Scholar
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel
Nausheen Ahmed, William Wesson, F. Lutfi, David L. Porter +12 more
2024Blood Advances39 citations
Semantic Scholar
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma
M. Scordo, J. Flynn, M. Gonen, S. Devlin +18 more
2023Blood Advances33 citations Open access
Semantic Scholar
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis
P. Riedell, Connor B. Grady, L. Nastoupil, Alejandro Luna +13 more
2024Blood Advances28 citations Open access
Semantic Scholar
Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis
Andrea Chung, J. Shafrin, Sachin Vadgama, K. Hurley +6 more
2025Blood Advances25 citations
Semantic Scholar
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected anti-retroviral therapy-suppressed macaques
Helen L. Wu, K. Busman-Sahay, W. Weber, Courtney M. Waytashek +39 more
2023Immunity25 citations
Semantic Scholar
Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial
Ciara L. Freeman, B. Dhakal, G. Kaur, R. Maziarz +21 more
2024Blood21 citations
Semantic Scholar
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient
R. Maziarz, S. Devine, Louis P. Garrison, I. Agodoa +3 more
2023Transplantation and Cellular Therapy21 citations Open access
Semantic Scholar
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN study.
C. Lachowiez, M. Heiblig, Gaspar Aspas Requena, Emmanuelle Tavernier-Tardy +28 more
2025Blood Cancer Discovery19 citations
Semantic Scholar
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma
N. Ahmed, William Wesson, M. Mushtaq, D. Porter +15 more
2023Transplantation and Cellular Therapy19 citations Open access
Semantic Scholar
CAR T-Cell Immunotherapy in Minority Patients with Lymphoma.
G. Ghilardi, S. Williamson, R. Pajarillo, L. Paruzzo +25 more
2024NEJM Evidence18 citations
Semantic Scholar
Itacitinib for the Prevention of IEC Therapy-Associated CRS: Results From the Two-Part Phase 2 INCB 39110-211 Study.
M. Frigault, R. Maziarz, Jae H. Park, Aleksander Lazaryan +10 more
2025Blood17 citations Open access
Semantic Scholar
Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective
R. Maziarz, U. Gergis, Marie Louise Edwards, Yan Song +7 more
2023Blood Advances16 citations Open access
Semantic Scholar
A phase 1, first-in-human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2-overexpressing solid tumors.
Y. Abdou, E. Dees, J. Mortimer, P. Pohlmann +14 more
2023Journal of Clinical Oncology16 citations
Semantic Scholar
Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States
R. Maziarz, Hong-Bo Yang, Qing Liu, Travis Wang +5 more
2022Leukemia and Lymphoma15 citations Open access
Semantic Scholar
Itacitinib for the Prevention of Immune Effector Cell Therapy-Associated Cytokine Release Syndrome: Results from the Phase 2 Incb 39110-211 Placebo-Controlled Randomized Cohort
M. Frigault, R. Maziarz, Jae H. Park, A. Lazaryan +9 more
2023Blood14 citations Open access
Semantic Scholar
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
Chenyu Lin, Aurélie Schwarzbach, J. Sanz, P. Montesinos +29 more
2023Transplantation and Cellular Therapy13 citations Open access
Semantic Scholar
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on behalf of The American Society of Transplantation and Cellular Therapy and the European Society of Blood and Marrow Transplantation.
M. Iqbal, Ambuj Kumar, P. Dreger, Julio Chavez +24 more
2024Transplantation and Cellular Therapy12 citations Open access
Semantic Scholar
Immune-related adverse events associated with cancer immunotherapy.
Smith Kungwankiattichai, Amrita Desai, Shelby Koppinger, R. Maziarz
2025i Medicina11 citations
Semantic Scholar
“Don't keep me waiting”: estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes
Sachin Vadgama, Marcelo C. Pasquini, R. Maziarz, Zhen-Huan Hu +6 more
2024Blood Advances11 citations Open access
Semantic Scholar
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study
P. McCarthy, K. Attwood, Xiaojun Liu, George Chen +17 more
2023Bone Marrow Transplantation10 citations Open access
Semantic Scholar
Efficacy and Safety of Tisagenlecleucel in Patients with Relapsed/Refractory Follicular Lymphoma: A Real-World Analysis from the Center for Blood and Marrow Transplant Research (CIBMTR) Registry
D. Landsburg, R. Maziarz, A. Moskop, L. Popplewell +8 more
2024Blood9 citations
Semantic Scholar
Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium
P. Riedell, Connor B. Grady, L. Nastoupil, Alejandro Luna +13 more
2023Blood9 citations Open access
Semantic Scholar
Interim Results from a Phase 2 Pivotal Study (DALY II USA) of Tandem CD20-CD19-Directed Non-Cryopreserved CAR-T Cells - Zamtocabtagene Autoleucel (Zamto-Cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
N. Shah, R. Maziarz, C. Jacobson, Patrick B. Johnston +23 more
2024Blood8 citations
Semantic Scholar
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas
A. Mirza, C. Hosing, F. Foss, Soyoung Kim +38 more
2025Blood neoplasia7 citations Open access
Semantic Scholar
Rates of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) from Center for International Blood and Marrow Transplant Research (CIBMTR) data on US subjects (SUBJ) with lymphoma following chimeric antigen receptor T cell therapy (CAR-T).
M. Frigault, T. Amoloja, L. Burke, R. Morariu-Zamfir +6 more
2023Journal of Clinical Oncology7 citations Open access
Semantic Scholar
A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation
J. Bubalo, J. Radke, K. Bensch, Andy I. Chen +2 more
2023Journal of Oncology Pharmacy Practice7 citations Open access
Semantic Scholar
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.
Somya Khare, S. Williamson, Brittany O'Barr, L. Schachter +9 more
2024Clinical Lymphoma, Myeloma & Leukemia6 citations
Semantic Scholar
P1134: BISPECIFIC ANTI-CD20/19 CAR-T – ZAMTOCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY DLBCL – INTERIM ANALYSIS RESULTS OF DALY-II-USA STUDY
N. Shah, R. Maziarz, C. Jacobson, I. Isufi +13 more
2023HemaSphere6 citations Open access
Semantic Scholar
Long Term Durable Responses in Relapsed/Refractory (r/r) ALL, DLBCL, and FL Patients Treated with Tisagenlecleucel and Its Association with Persistence of CAR T-Cells
R. Awasthi, Edward R. Waldron, S. Grupp, M. Pulsipher +10 more
2023Blood6 citations Open access
Semantic Scholar
Cost-Effectiveness of Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients with High-Risk Myelodysplastic Syndrome: Analysis of BMT-CTN 1102
Scott D. Ramsey, W. Saber, A. Bansal, Lily Li +13 more
2024JCO Oncology Practice4 citations Open access
Semantic Scholar
A retrospective single-center analysis of CD-19 directed CAR T-cell therapy in relapsed/refractory mantle cell lymphoma
Titas Banerjee, M. Newman, Andy I. Chen, R. Maziarz +3 more
2023Leukemia and Lymphoma4 citations
Semantic Scholar
Prognostic Significance of NCAM1 (CD56) Expression in AML Patients Treated with HMA+Venetoclax
Jennifer N. Saultz, Manoj Rai, Faith Burns, Daniel J Chandra +20 more
2023Blood4 citations Open access
Semantic Scholar
Results of a Phase 1 Trial Testing the Novel Combination Therapy of Venetoclax and Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia Patients
U. Borate, Y. Madanat, C. Tognon, Shikha Mishra +25 more
2023Blood4 citations Open access
Semantic Scholar
INTERIM RESULTS OF TANDEM CD20‐CD19‐DIRECTED NON‐CRYOPRESERVED CAR‐T CELLS—ZAMTOCABTAGENE AUTOLEUCEL IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
N. Shah, R. Maziarz, C. Jacobson, P. Johnston +24 more
2025Hematological Oncology3 citations
Semantic Scholar
The history of cytokines and growth factors development.
Smith Kungwankiattichai, R. Maziarz
2025Baillière's Best Practice & Research: Clinical Haematology3 citations
Semantic Scholar
Hospitalization and Healthcare Resource Utilization of Omidubicel-onlv Versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis From a Pivotal Phase 3 Clinical Trial.
N. Majhail, Beckley Miller, R. Dean, R. Manghani +3 more
2023Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: Final Report of BMT CTN 2002
G. Meyers, M. Hamadani, Michael J. Martens, H. Ali +21 more
2023Bone Marrow Transplantation3 citations Open access
Semantic Scholar
Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation- A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement & Transplantation Network Study
Meera Gupta, M. Schoettler, R. Brazauskas, Stephanie Bo-Subait +29 more
2025Transplantation2 citations Open access
Semantic Scholar
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program.
Mitchell Horwitz, Gary Schiller, Stephanie B. Tsai, Andrew R. Rezvani +6 more
2025Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
Tandem CD20-CD19-Directed Non-Cryopreserved CAR T Cells - Zamtocabtagene Autoleucel (Zamto-Cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Interim Results from a Phase 2 Pivotal Study (DALY II USA)
Nirav N. Shah, R. Maziarz, C. Jacobson, Patrick B. Johnston +24 more
2025Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation- A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement & Transplantation Network (OPTN) Study
Meera Gupta, M. Schoettler, Gabriel Orozco, R. Brazauskas +29 more
2025Transplantation2 citations Open access
Semantic Scholar
Immunophenotypic Markers CD7 and CD56 Improve Risk Stratification of Frontline Hypomethylating Agents + Venetoclax in Newly Diagnosed AML
C. Lachowiez, Daniel T. Peters, Jacob Fang, A. Kaempf +13 more
2024Blood2 citations
Semantic Scholar
CAR T Cell Therapy in Early Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium
A. Rojek, N. Ahmed, M. Gomez-Llobell, Sairah Ahmed +14 more
2024Blood2 citations
Semantic Scholar
A new beginning: can omidubicel emerge as the next, viable alternative donor source?
A. Gandhi, L. Newell, R. Maziarz
2023Therapeutic Advances in Hematology2 citations Open access
Semantic Scholar
Omidubicel-Onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies: Results of a Multicenter Open Label Expanded Access Program
Mitchell E. Horwitz, Stephanie B. Tsai, Andrew R. Rezvani, R. Maziarz +6 more
2023Blood2 citations
Semantic Scholar
“Defining the Optimal Post-CART Monitoring Period in Recipients of Axicabtagene Ciloleucel and Tisagenlecleucel”
William Wesson, F. Lutfi, David L. Porter, V. Bachanova +12 more
2023Blood2 citations Open access
Semantic Scholar
Serial Transthoracic Ultrasonography Studies in Hematopoietic Cell Transplant Patients: A Tool for Early Lung Pathology Detection.
Meihua Zhu, Cynthia Gregory, B. Hayes-Lattin, C. Jacoby +5 more
2022Ultrasound in Medicine and Biology2 citations
Semantic Scholar
Impact of ABO Compatibility on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT): Ptcy Impacts Platelet Engraftment, Independent of ABO Compatibility
Mikayla Murphy, Yun Yu, R. Knight, Krislynd Estalilla +6 more
2024Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
NCAM1 (CD56) As a Predictor of Response to Standard Intensive Induction in Newly Diagnosed Acute Myeloid Leukemia
Jennifer N. Saultz, Manoj Rai, A. Kaempf, Sanjog Bastola +13 more
2024Blood1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Olalekan O. Oluwole×8
Invite
Olalekan O. Oluwole — researcher profile on SciRah
P. Riedell×8
Invite
P. Riedell — researcher profile on SciRah
M. Perales×7
Invite
M. Perales — researcher profile on SciRah
L. Nastoupil×6
Invite
L. Nastoupil — researcher profile on SciRah

Jospeh P. McGuirk

×6

Invite

Jospeh P. McGuirk — researcher profile on SciRah

Invite

L. Newell — researcher profile on SciRah

Jamie Brower×5

Invite

Jamie Brower — researcher profile on SciRah

Invite

S. Schuster — researcher profile on SciRah

Invite

A. Kaempf — researcher profile on SciRah

Gabrielle Meyers×5

Invite

Gabrielle Meyers — researcher profile on SciRah

Invite

A. Gandhi — researcher profile on SciRah

Invite

E. Traer — researcher profile on SciRah